diagnost tool
deliv mix set bar
allevi overhang hold pt
deliv mix highlight top line growth gross margin declin
y/i initi ep guid came us street
midpoint believ stock today remov uncertainti
regard guid announc agreement renew lh
think allevi modest overhang stock top line guid
growth enough us get excit look sign faster
growth progress mitig margin drag reiter hold rais pt
roll forward multipl new adj ep
allevi lab contract overhang agre deal larg lab custom
lh posit outcom modest overhang stock one deal multi-
year extens suppli contract provid instrument test
view deal favor believ like made price concess
deal
strength breast health rev beat new
product launch perform continu reson gyn
surgic grew ahead molecular diagnost rev
continu reson panther util rose doubl digit y/i
instal base panther
challeng cynosur remain overhang revenu miss us
declin y/i revers compani origin goal declin gm om
uncertainti mitig pressur go
cyno rev y/i miss howev telegraph
earlier quarter pull tempsur vitalia market aesthet
use coupl pressur relat mona lisa touch letter guid
quarter indic normal sale forc
compani still open fill
gm pressur adj gm y/i miss due mix
higher sale lower-margin ou cyno product lower rev higher
margin surgic product flat y/i fxn
rev rep fxn miss beat
consensu adj ep miss our/street
guid initi rev rep
adj ep guid rep
vs street similarli guid rev our/
street adj ep our/street
guidanc pattern proven consist manag team
 a/model impact quantifi recent tuck-in acquisit faxitron bioptic
revenu base grow double-digit
ad model rev
global leader diagnost breast
imag surgic product focu women
health offer medic aesthet
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
growth segment expect revenu segment gener low-to-
mid singl digit revenu growth except breast health segment
target mid-single-digit growth impli forecast miss
aspir goal achiev double-digit growth medic aesthet divis
hold unchang target price novemb
diagnost tool
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
hold unchang target price novemb
diagnost tool
hold unchang target price novemb
diagnost tool
